Mansour 2011.

Trial name or title	Comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction (COMPARE‐AMI)
Methods	Type of study: parallel RCT Source of funding: fonds de la recherche en santé du Québec, Miltenyi Biotec, Inc., and Boston Scientific in Canada Country of origin: Canada Number of centres: 1 Intended enrolment: not reported
Participants	Population: AMI Age, mean (SD) each arm: 52.2 (8.9) years Sex, % male in each arm: 90% male Number of diseased vessels: not reported Number of stunned hyperkinetic, etc segments: not reported Time from symptom onset to initial treatment: not reported Statistically significant baseline imbalances between the groups?: not reported
Interventions	Intervention arm: BMSC Type of stem cells: bone marrow‐derived CD133‐positive cells Summary of how stem cells were isolated and type and route of delivery: BM aspiration and separation of mononuclear cells using gradient centrifugation. CD133‐positive cells were immunomagnetically separated using the Clinimacs (Miltenyi) Dose of stem cells: not reported Timing of stem cell procedure: < 12 hours Comparator arm: saline and 10% autologous plasma
Outcomes	Primary outcomes: safety and efficacy and functional effect of the treatment Secondary outcomes: not reported Outcome assessment points: baseline, 4 months and 12 months Method(s): echocardiography, MRI, LV angiography
Starting date	—
Contact information	—
Notes	—